683 related articles for article (PubMed ID: 30787155)
21. Kaposi's sarcoma-associated herpesvirus-induced angiogenin plays roles in latency via the phospholipase C gamma pathway: blocking angiogenin inhibits latent gene expression and induces the lytic cycle.
Sadagopan S; Valiya Veettil M; Paudel N; Bottero V; Chandran B
J Virol; 2011 Mar; 85(6):2666-85. PubMed ID: 21209106
[TBL] [Abstract][Full Text] [Related]
22. Activation of Akt through gp130 receptor signaling is required for Kaposi's sarcoma-associated herpesvirus-induced lymphatic reprogramming of endothelial cells.
Morris VA; Punjabi AS; Lagunoff M
J Virol; 2008 Sep; 82(17):8771-9. PubMed ID: 18579585
[TBL] [Abstract][Full Text] [Related]
23. Reactive oxygen species are induced by Kaposi's sarcoma-associated herpesvirus early during primary infection of endothelial cells to promote virus entry.
Bottero V; Chakraborty S; Chandran B
J Virol; 2013 Feb; 87(3):1733-49. PubMed ID: 23175375
[TBL] [Abstract][Full Text] [Related]
24. A role for virally induced reactive oxygen species in Kaposi's sarcoma herpesvirus tumorigenesis.
Ma Q; Cavallin LE; Leung HJ; Chiozzini C; Goldschmidt-Clermont PJ; Mesri EA
Antioxid Redox Signal; 2013 Jan; 18(1):80-90. PubMed ID: 22746102
[TBL] [Abstract][Full Text] [Related]
25. Modified Cross-Linking, Ligation, and Sequencing of Hybrids (qCLASH) Identifies Kaposi's Sarcoma-Associated Herpesvirus MicroRNA Targets in Endothelial Cells.
Gay LA; Sethuraman S; Thomas M; Turner PC; Renne R
J Virol; 2018 Apr; 92(8):. PubMed ID: 29386283
[TBL] [Abstract][Full Text] [Related]
26. Oncogenic Kaposi's Sarcoma-Associated Herpesvirus Upregulates Argininosuccinate Synthase 1, a Rate-Limiting Enzyme of the Citrulline-Nitric Oxide Cycle, To Activate the STAT3 Pathway and Promote Growth Transformation.
Li T; Zhu Y; Cheng F; Lu C; Jung JU; Gao SJ
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463977
[TBL] [Abstract][Full Text] [Related]
27. Hace1 controls ROS generation of vertebrate Rac1-dependent NADPH oxidase complexes.
Daugaard M; Nitsch R; Razaghi B; McDonald L; Jarrar A; Torrino S; Castillo-Lluva S; Rotblat B; Li L; Malliri A; Lemichez E; Mettouchi A; Berman JN; Penninger JM; Sorensen PH
Nat Commun; 2013; 4():2180. PubMed ID: 23864022
[TBL] [Abstract][Full Text] [Related]
28. KSHV requires vCyclin to overcome replicative senescence in primary human lymphatic endothelial cells.
DiMaio TA; Vogt DT; Lagunoff M
PLoS Pathog; 2020 Jun; 16(6):e1008634. PubMed ID: 32555637
[TBL] [Abstract][Full Text] [Related]
29. Viral MicroRNAs Repress the Cholesterol Pathway, and 25-Hydroxycholesterol Inhibits Infection.
Serquiña AKP; Kambach DM; Sarker O; Ziegelbauer JM
mBio; 2017 Jul; 8(4):. PubMed ID: 28698273
[TBL] [Abstract][Full Text] [Related]
30. CIB1 synergizes with EphrinA2 to regulate Kaposi's sarcoma-associated herpesvirus macropinocytic entry in human microvascular dermal endothelial cells.
Bandyopadhyay C; Valiya-Veettil M; Dutta D; Chakraborty S; Chandran B
PLoS Pathog; 2014 Feb; 10(2):e1003941. PubMed ID: 24550731
[TBL] [Abstract][Full Text] [Related]
31. Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors.
Carroll PA; Kenerson HL; Yeung RS; Lagunoff M
J Virol; 2006 Nov; 80(21):10802-12. PubMed ID: 16956952
[TBL] [Abstract][Full Text] [Related]
32. Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion.
Sharma-Walia N; Paul AG; Bottero V; Sadagopan S; Veettil MV; Kerur N; Chandran B
PLoS Pathog; 2010 Feb; 6(2):e1000777. PubMed ID: 20169190
[TBL] [Abstract][Full Text] [Related]
33. Cytotoxic Drugs Activate KSHV Lytic Cycle in Latently Infected PEL Cells by Inducing a Moderate ROS Increase Controlled by HSF1, NRF2 and p62/SQSTM1.
Granato M; Gilardini Montani MS; Angiolillo C; D'Orazi G; Faggioni A; Cirone M
Viruses; 2018 Dec; 11(1):. PubMed ID: 30586869
[TBL] [Abstract][Full Text] [Related]
34. Kaposi's Sarcoma-Associated Herpesvirus Nonstructural Membrane Protein pK15 Recruits the Class II Phosphatidylinositol 3-Kinase PI3K-C2α To Activate Productive Viral Replication.
Abere B; Samarina N; Gramolelli S; Rückert J; Gerold G; Pich A; Schulz TF
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950425
[TBL] [Abstract][Full Text] [Related]
35. Oxidative stress induces reactivation of Kaposi's sarcoma-associated herpesvirus and death of primary effusion lymphoma cells.
Li X; Feng J; Sun R
J Virol; 2011 Jan; 85(2):715-24. PubMed ID: 21068240
[TBL] [Abstract][Full Text] [Related]
36. Kaposi's sarcoma-associated herpesvirus interacts with EphrinA2 receptor to amplify signaling essential for productive infection.
Chakraborty S; Veettil MV; Bottero V; Chandran B
Proc Natl Acad Sci U S A; 2012 May; 109(19):E1163-72. PubMed ID: 22509030
[TBL] [Abstract][Full Text] [Related]
37. Kaposi's sarcoma-associated herpesvirus upregulates angiogenin during infection of human dermal microvascular endothelial cells, which induces 45S rRNA synthesis, antiapoptosis, cell proliferation, migration, and angiogenesis.
Sadagopan S; Sharma-Walia N; Veettil MV; Bottero V; Levine R; Vart RJ; Chandran B
J Virol; 2009 Apr; 83(7):3342-64. PubMed ID: 19158252
[TBL] [Abstract][Full Text] [Related]
38. KSHV hijacks FoxO1 to promote cell proliferation and cellular transformation by antagonizing oxidative stress.
Li T; Gao SJ
J Med Virol; 2023 Mar; 95(3):e28676. PubMed ID: 36929740
[TBL] [Abstract][Full Text] [Related]
39. Bone Marrow-Derived SH-SY5Y Neuroblastoma Cells Infected with Kaposi's Sarcoma-Associated Herpesvirus Display Unique Infection Phenotypes and Growth Properties.
Kong X; Li D; Mansouri A; Kang G; Sayood K; West J; Wood C
J Virol; 2021 Jun; 95(13):e0000321. PubMed ID: 33853962
[TBL] [Abstract][Full Text] [Related]
40. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.
Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
